Practical Experience! Key Considerations for Safety Testing of Pharmaceutical and Medical Device Packaging During Transportation

Potential risks during the transportation of pharmaceuticals and medical devices can compromise drug quality and efficacy, jeopardizing their safety and effectiveness—and ultimately leading to adverse effects on patients' treatment outcomes and overall health. That’s why transportation safety testing for pharmaceutical and medical device packaging—specifically pharmaceutical packaging testing and medical device packaging testing—is conducted with utmost rigor.

The general standard for pharmaceutical packaging testing and medical device packaging testing is ASTM D4169 This standard provides guidelines for evaluating the environmental resilience of transport packaging under laboratory conditions, specifying the conditions that transport items may encounter. 18 Type of delivery cycle Distribution Cycle ， DC ) and the corresponding test procedures.

Each test procedure consists of several test items (such as drop tests, vibration tests, pressure tests, and more). In particular, the specific test conditions for pharmaceutical packaging testing and medical device packaging testing must be determined based on the confidence level established by the tester. Assurance level ) To select or formulate.

ASTM D4169 The general acceptance criteria provided are primarily based on two key aspects: intact packaging and undamaged products, making them suitable for packaging tests of virtually any product. However, considering the unique characteristics of pharmaceuticals, even when identical transportation methods are used, the associated risks can vary significantly depending on the specific drug. Therefore, it is essential to conduct purposeful, targeted selection of different testing methods and conditions for packaging evaluations of various pharmaceutical products and medical device packaging—always grounded in a sound and effective risk analysis.

Now, let’s discuss this based on the center’s years of hands-on experience. ASTM D4169 Standard provisions clearly defined for pharmaceutical and medical device packaging, specifically relevant to drug packaging testing and medical device packaging inspection.

ASTM D4169 The test strength level for the shipping package has been established.

Guaranteed quality It refers to the test intensity level adopted based on the likelihood of a particular risk occurring during the transportation packaging process. Before testing begins, it’s essential to comprehensively consider factors such as the value of the transported product, the expected tolerable degree of damage, the quantity of goods, and insights into the transportation environment—allowing you to clearly define the assurance level for each test item.

Based on the test intensity and the probability of risk occurrence, the assurance levels are divided into: I 、 II 、III3 Level. Among them I The level test is quite challenging, III The test at this level is the weakest in intensity, II Moderate level. ASTM D4169 Test conditions have been set for each test item under different assurance levels, as shown in the table. 1 “Project A "Loading and Unloading Test: Free Drop Test Conditions."

Table 1 Project A Loading and Unloading Test: Free Drop Test Conditions

ASTM D4169 Outlines the transportation risks and testing items associated with shipping packages during transit.

ASTM D4169 Clearly outlines the potential risks and hazards encountered during transportation, and sets up corresponding test items to simulate or replicate these risk factors (Table 2 ). The table covers processes such as loading and unloading, stacking, and vehicle transportation in the distribution process, primarily using test methods like drop tests, impact tests, pressure tests, and vibration tests.

Table 2 Transportation Risks and Testing Items

ASTM D4169 The transportation packaging delivery cycle and the corresponding test plan have been clearly defined.

Delivery Cycle Broadly speaking, it can be understood as the entire distribution environment that a shipping package may encounter—from the moment production is completed until the product reaches the consumer. ASTM D4169 It is defined as a test checklist listing all the experimental items in sequence, as shown in the table. 3。

Table 3 Delivery Cycle and Corresponding Testing Plan

ASTM D4169 A general procedure for testing the performance of transport packaging has been established.

1. Understand the relevant characteristics of transport packaging (e.g., dimensions, weight, structural design, and methods of handling during transportation—whether manual or mechanical).
2. Clearly define the assurance level for the test items.
3. Establish acceptable criteria for the test experiment.
4. From the table 3 Select the delivery cycle that most closely matches your preferred shipping method.

When developing pharmaceuticals and medical devices, it is recommended that developers first thoroughly understand the distribution environments the products are likely to encounter—or have already experienced—during their lifecycle. Based on this understanding of external conditions and the specific characteristics of the product, they should carefully assess potential risks and determine the extent to which these risks could impact or harm the product.

After completing pharmaceutical packaging and medical device packaging tests, if the results indicate that the current packaging is insufficient to effectively ensure the quality and safety of the medication during transportation, developers can either refine the existing packaging method to enhance its protective performance—or alternatively, adjust the original shipping plan to mitigate transportation risks—ultimately meeting the critical quality requirements for drug delivery.

The general standards for pharmaceutical packaging testing and medical device packaging testing ASTM D4169 If there’s anything you’re still unclear about, feel free to give us a call.